Literature DB >> 12604976

Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.

J Crone1, G Granditsch, W-D Huber, C Binder, A Innerhofer, G Amann, A M Hirschl.   

Abstract

BACKGROUND: The authors evaluate the prevalence of Helicobacter pylori resistance in 117 children and demonstrate the changes over a 4-year period.
METHODS: In 117 children and adolescents, H. pylori-positive gastritis was revealed by diagnostic upper endoscopy. Biopsies from the antrum and body of the stomach were tested by histology, urease test, and culture. H. pylori was isolated using standard culture techniques, and susceptibility to amoxicillin, clarithromycin, and metronidazole was tested using the E-test (AB-Biodisk, Sweden).
RESULTS: Endoscopy revealed gastric ulcers in 2 of 117 subjects, duodenal ulcers in 6 of 117, and erosive gastritis or duodenitis in 23 of 117. Almost all patients showed antral nodularity. Histology always showed chronic gastritis with different degrees of activity. During the 4-year study period, the authors noticed an increase of primary clarithromycin-resistant H. pylori strains, from 14.3% to 27.6% (mean, 20.3%). Metronidazole resistance varied between 5% and 25%. No resistance to amoxicillin was found.
CONCLUSION: Eradication of H. pylori should take place only after testing of susceptibility. The general use of clarithromycin in children should be restricted to better-defined indications. Resistance to clarithromycin of H. pylori may also become a future problem for the treatment of adults.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604976     DOI: 10.1097/00005176-200303000-00012

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 2.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

3.  Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.

Authors:  Seyed Amir Mirbagheri; Mehrdad Hasibi; Mehdi Abouzari; Armin Rashidi
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

4.  The antibacterial activity of honey on helicobacter pylori.

Authors:  Basil C Nzeako; Faiza Al-Namaani
Journal:  Sultan Qaboos Univ Med J       Date:  2006-12

5.  Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.

Authors:  S Koletzko; F Richy; P Bontems; J Crone; N Kalach; M L Monteiro; F Gottrand; D Celinska-Cedro; E Roma-Giannikou; G Orderda; S Kolacek; P Urruzuno; M J Martínez-Gómez; T Casswall; M Ashorn; H Bodanszky; F Mégraud
Journal:  Gut       Date:  2006-04-07       Impact factor: 23.059

6.  Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.

Authors:  Jungi Choi; Joo Young Jang; Joon Sung Kim; Hwa Young Park; Yon Ho Choe; Kyung Mo Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

7.  High level of resistance to metronidazole and clarithromycin in Helicobacter pylori isolated from pediatric patients in Poland (1997-2001).

Authors:  G Gościniak; B Iwańczak; A Przondo-Mordarska; J Grabińska; F Iwańczak
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

8.  New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.

Authors:  Benjamin D Gold; Mark A Gilger; Steven J Czinn
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-12

9.  Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy.

Authors:  Marco Manfredi; Pierpacifico Gismondi; Valentina Maffini; Barbara Bizzarri; Fabiola Fornaroli; Carmen Madia; Antonino Salerno; A Marta Cangelosi; Gian Luigi de'Angelis
Journal:  Gastroenterol Res Pract       Date:  2015-05-06       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.